Lv7
4968 积分 2022-08-08 加入
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
10小时前
已完结
Phase 2a Study of Baxdrostat in Primary Aldosteronism
1天前
已完结
Aldosterone synthase inhibition: a novel bullet to fight cardiovascular–kidney–metabolic syndrome
1天前
求助中
Aldosterone Synthase Inhibition in Hypertension
1天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
3天前
已完结
Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis
1个月前
已关闭
Insulin allergy
1个月前
已关闭
Subcutaneous Injectable Drugs Hypersensitivity and Desensitization
1个月前
已完结
A Characterization of the Nonclinical Pharmacology and Toxicology of Aficamten, a Reversible Allosteric Inhibitor of Cardiac Myosin
1个月前
已完结
CTL recognition of an altered peptide associated with asparagine bond rearrangement. Implications for immunity and vaccine design
1个月前
已完结
皖公网安备34019202002308
